Transurethral evaporation treats benign prostatic hyperplasia (BPH):
This article was originally published in Clinica
Executive Summary
Transurethral evaporation of the prostate can cut irratative voiding complications to 22.6% say researchers from the University of Florida in Gainesville and the University of New Mexico in Albuquerque. The researchers used the technique to treat effectively benign prostatic hyperplasia (BPH) in a 168-patient study at two US sites. They found complications associated with the treatment were minimal after 12-month follow up. Patients also demonstrated a significant improvement in mean peak flow rate from 8.2 to 18.2 cm3 per second reports the Journal of Urology (Vol 157, p 1309-1312).
You may also be interested in...
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.